Cargando…
Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
SIMPLE SUMMARY: The claudin (CLDN) family, the backbone of tight junctions, consists of more than 20 members in humans, and exhibits distinct expression patterns in tissue- and cell-type-specific manners. Among the CLDN members, CLDN6 is primarily expressed in diverse embryonic epithelial cells. It...
Autores principales: | Kojima, Manabu, Sugimoto, Kotaro, Tanaka, Mizuko, Endo, Yuta, Kato, Hitomi, Honda, Tsuyoshi, Furukawa, Shigenori, Nishiyama, Hiroshi, Watanabe, Takafumi, Soeda, Shu, Fujimori, Keiya, Chiba, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656298/ https://www.ncbi.nlm.nih.gov/pubmed/32987797 http://dx.doi.org/10.3390/cancers12102748 |
Ejemplares similares
-
Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748
por: Kojima, Manabu, et al.
Publicado: (2021) -
Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022) -
Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer
por: Rahman, Abidur, et al.
Publicado: (2021) -
SPON1 is an independent prognostic biomarker for ovarian cancer
por: Miyakawa, Ryoya, et al.
Publicado: (2023) -
Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy
por: Furukawa, Shigenori, et al.
Publicado: (2015)